Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medifast (MED) Shares Outstanding (Diluted Average) (2016 - 2025)

Medifast (MED) has disclosed Shares Outstanding (Diluted Average) for 16 consecutive years, with $11.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) changed 0.16% year-over-year to $11.0 million, compared with a TTM value of $11.0 million through Dec 2025, changed 0.16%, and an annual FY2025 reading of $11.0 million, changed 0.16% over the prior year.
  • Shares Outstanding (Diluted Average) was $11.0 million for Q4 2025 at Medifast, roughly flat from $11.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $11.9 million in Q1 2021 and bottomed at $10.9 million in Q1 2023.
  • Average Shares Outstanding (Diluted Average) over 5 years is $11.2 million, with a median of $11.0 million recorded in 2025.
  • The sharpest move saw Shares Outstanding (Diluted Average) soared 24604.17% in 2021, then fell 6.35% in 2023.
  • Year by year, Shares Outstanding (Diluted Average) stood at $11.8 million in 2021, then decreased by 4.55% to $11.3 million in 2022, then fell by 3.15% to $10.9 million in 2023, then grew by 0.38% to $11.0 million in 2024, then increased by 0.16% to $11.0 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for MED at $11.0 million in Q4 2025, $11.0 million in Q3 2025, and $11.0 million in Q2 2025.